A quality improvement project improving the value of iNO utilization in preterm and term infants.
Journal
Journal of perinatology : official journal of the California Perinatal Association
ISSN: 1476-5543
Titre abrégé: J Perinatol
Pays: United States
ID NLM: 8501884
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
27
02
2020
accepted:
28
07
2020
revised:
26
06
2020
pubmed:
10
8
2020
medline:
1
9
2021
entrez:
10
8
2020
Statut:
ppublish
Résumé
Inhaled NO (iNO) is used in the NICU for management of hypoxemic respiratory failure. The cost of iNO is significant and does not consistently improve outcomes in infants <34 weeks. Our team used The Model for Improvement to design a quality improvement project to utilize iNO for appropriate indications, ensure response to therapy and initiate timely weaning. The project was carried out at a Level IV NICU and successful interventions spread to a smaller Level III NICU. This project demonstrated significant improvement in all measures; total iNO hours per month, average iNO hours per patient, and the percentage of prolonged iNO courses. With an estimated cost of $115/h, the cost per patient for iNO use declined by half from $21,620 to $10,580. Our team improved the value of iNO utilization at our institution and spread successful interventions to another NICU in our network.
Identifiants
pubmed: 32770031
doi: 10.1038/s41372-020-0768-0
pii: 10.1038/s41372-020-0768-0
doi:
Substances chimiques
Nitric Oxide
31C4KY9ESH
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
164-172Références
Barrington KJ, Finer N, Pennaforte T, Altit G. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev. 2017;1:Cd000399.
pubmed: 28056166
Barrington KJ, Finer N, Pennaforte T. Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev. 2017;1:Cd000509.
pubmed: 28045472
Witzmann K. Medical officer review: INOmax; 2010. https://www.fda.gov/media/80208/download .
Cole FS, Alleyne C, Barks JD, Boyle RJ, Carroll JL, Dokken D, et al. NIH consensus development conference: inhaled nitric oxide therapy for premature infants. NIH Consens State Sci Statements. 2010;27:1–34.
pubmed: 21042341
Kumar P. Use of inhaled nitric oxide in preterm infants. Pediatrics. 2014;133:164–70.
doi: 10.1542/peds.2013-3444
Manja V, Guyatt G, Lakshminrusimha S, Jack S, Kirpalani H, Zupancic JAF, et al. Factors influencing decision making in neonatology: inhaled nitric oxide in preterm infants. J Perinatol. 2019;39:86–94.
doi: 10.1038/s41372-018-0258-9
Ellsworth MA, Harris MN, Carey WA, Spitzer AR, Clark RH. Off-label use of inhaled nitric oxide after release of NIH consensus statement. Pediatrics. 2015;135:643–8.
doi: 10.1542/peds.2014-3290
Watson RS, Clermont G, Kinsella JP, Kong L, Arendt RE, Cutter G, et al. Clinical and economic effects of iNO in premature newborns with respiratory failure at 1 year. Pediatrics. 2009;124:1333–43.
doi: 10.1542/peds.2009-0114
Lorch SA, Cnaan A, Barnhart K. Cost-effectiveness of inhaled nitric oxide for the management of persistent pulmonary hypertension of the newborn. Pediatrics. 2004;114:417–26.
doi: 10.1542/peds.114.2.417
Elmekkawi A, More K, Shea J, Sperling C, Da Silva Z, Finelli M, et al. Impact of Stewardship on inhaled nitric oxide utilization in a neonatal ICU. Hosp Pediatr. 2016;6:607–15.
doi: 10.1542/hpeds.2016-0003
Todd Tzanetos DR, Housley JJ, Barr FE, May WL, Landers CD. Implementation of an inhaled nitric oxide protocol decreases direct cost associated with its use. Respir Care. 2015;60:644–50.
doi: 10.4187/respcare.03308
Hughes Driscoll CA, Davis NL, Miles M, El-Metwally D. A quality improvement project to improve evidence-based inhaled nitric oxide use. Respir Care. 2018;63:20–7.
doi: 10.4187/respcare.05619
Ballard RA, Truog WE, Cnaan A, Martin RJ, Ballard PL, Merrill JD, et al. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med. 2006;355:343–53.
doi: 10.1056/NEJMoa061088
Askie LM, Ballard RA, Cutter GR, Dani C, Elbourne D, Field D, et al. Inhaled nitric oxide in preterm infants: an individual-patient data meta-analysis of randomized trials. Pediatrics. 2011;128:729–39.
doi: 10.1542/peds.2010-2725
Donohue PK, Gilmore MM, Cristofalo E, Wilson RF, Weiner JZ, Lau BD, et al. Inhaled nitric oxide in preterm infants: a systematic review. Pediatrics. 2011;127:e414–22.
doi: 10.1542/peds.2010-3428
Langley GJ. The improvement guide a practical approach to enhancing organizational performance. 2nd ed. Jossey-Bass: San Francisco; 2009. pp. 1. online resource (xxi, 490 p.).
Nolan TRR, Haraden C, Griffin FA. Improving the Reliability of Healthcare. In: IHI innovation series white paper Boston. Institute for Healthcare Improvement; 2004. www.ihi.org .
Provost LP, Murray SK. The health care data guide learning from data for improvement. 1st ed. Jossey-Bass: San Francisco, CA; 2011. pp. 1. online resource (xxviii, 445 pages).
Karsies TJ, Evans L, Frost R, Ayad O, McClead R. A quality improvement initiative to standardize use of inhaled nitric oxide in the PICU. Pediatr Qual Saf. 2017;2:e011.
doi: 10.1097/pq9.0000000000000011
Dukhovny D, Pursley DM, Kirpalani HM, Horbar JH, Zupancic JA. Evidence, quality, and waste: solving the value equation in neonatology. Pediatrics. 2016;137:e20150312.
doi: 10.1542/peds.2015-0312